Processes in atherogenesis: complement activation
- 25 July 1997
- journal article
- review article
- Published by Elsevier BV in Atherosclerosis
- Vol. 132 (2), 131-138
- https://doi.org/10.1016/s0021-9150(97)00100-7
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosisAmerican Heart Journal, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesionsAtherosclerosis, 1992
- The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivoInflammation Research, 1991
- The control of homologous lysisImmunology Today, 1991
- Human monocyte chemoattractant protein-1 (MCP-1)Immunology Today, 1990
- Functions and relevance of the terminal complement sequenceBlut: Zeitschrift für die Gesamte Blutforschung, 1990
- Complement receptors and regulatory proteins in human atherosclerotic lesions.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- IgG binding to cytoskeletal intermediate filaments activates the complement cascadeExperimental Cell Research, 1987
- Complement and arteriosclerosisAtherosclerosis, 1973